Genomics England Adopts Illumina’s BaseSpace Variant Interpreter for Cancer

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) and Genomics England announced today that Illumina is the primary variant interpretation and reporting software vendor for tumor and matched normal samples characterized as part of the 100,000 Genomes Project. In a little over a year since Illumina announced the Bioinformatics and Clinical Interpretation Partnership with Genomics England, the partnership has now set... Read more

DiaSorin and Tecan to collaborate in new platform development

Saluggia, Italy and Männedorf, Switzerland, June 23, 2017 – DiaSorin (FTSE Italy Mid Cap: DIA) and Tecan Group (SIX Swiss Exchange: TECN) announced today that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan’s Fluent® Laboratory Automation Solution as its Nucleic Acid extraction platform. The new platform will... Read more

PacBio Technology Resolves Complex Maize Genome, Driving Demand for Other Large-Scale AgBio Sequencing Projects

MENLO PARK, Calif., June 22, 2017 (GLOBE NEWSWIRE) — A new publication in Nature reveals the significant quality improvement afforded by Single Molecule, Real-Time (SMRT®) Sequencing for the maize genome, with implications for other complex crop and livestock genomes. This new PacBio® genome assembly, produced by scientists at Cold Spring Harbor Laboratory, the USDA’s Agricultural Research... Read more

PacBio Technology Resolves Complex Maize Genome, Driving Demand for Other Large-Scale AgBio Sequencing Projects

MENLO PARK, Calif., June 22, 2017 (GLOBE NEWSWIRE) — A new publication in Nature reveals the significant quality improvement afforded by Single Molecule, Real-Time (SMRT®) Sequencing for the maize genome, with implications for other complex crop and livestock genomes. This new PacBio® genome assembly, produced by scientists at Cold Spring Harbor Laboratory, the USDA’s Agricultural Research... Read more

Canopy Biosciences Announces Distribution Agreement with Cosmo Bio for Japan Life Science Market

Canopy Biosciences signs agreement with Cosmo Bio to sell gene engineering products in Japan ST. LOUIS, June 22, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC (“Canopy Biosciences”), an emerging provider of gene editing and personalized medicine technologies, announced a distributor agreement with Cosmo Bio Co., Ltd. (“Cosmo Bio“) for its TUNR Flexible Gene Editing technology in Japan. ... Read more

Beijing 4P Health Research Institute initiates China’s “100K Wellness Pioneer Project” using UniteGen and Sapientia™ integrated platform

Commercial agreement with Congenica supports UniteGen’s goal of achieving the world’s largest human genome database Cambridge, UK – 21st June –  Congenica’s Sapientia™ clinical genome analysis software platform will be used by China-based UniteGen to carry out whole genome sequencing (WGS) processing and analysis as part of China’s “100K Wellness Pioneer Project”, hosted by Beijing... Read more

Twist Bioscience and the BioBricks Foundation Announce First-of-its-Kind Partnership to Provide 10,000 Public-Benefit Genes to the Synthetic Biology Community

SAN FRANCISCO, June 15, 2017 /PRNewswire/ — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, and the BioBricks Foundation today announced a groundbreaking agreement to provide 10,000 genes to the synthetic biology community. Under the terms of the agreement, the BioBricks Foundation (BBF) will pay for synthesis of 10,000 genes from... Read more

Alpaqua Introduces The Magnum FLX®24 Universal 24-well Magnet Plate Based On Its Patented Solid-Core Ring Magnet Technology

Enabling Product for Automated, Large Volume cell free DNA (cfDNA) Isolation The Magnum FLX24 Universal 24-well Magnet Plate provides unprecedented flexibility for large volume, magnetic bead-based extractions of nucleic acids or proteins with the quality and speed you have come to expect from Alpaqua magnet plates. The Magnum … BEVERLY, Mass., June 15, 2017 /PRNewswire/... Read more

Twist Bioscience Raises Additional $27 Million

JUN 14, 2017 — Aggregate New Funding in 2017 Reaches $60 Million; Total of $191 Million Raised Since Inception – — Accelerates Growth into Drug Discovery, Supports Investment in DNA Data Storage – SAN FRANCISCO, Calif. – June 14, 2017 – Twist Bioscience Corporation, a company accelerating science and innovation through rapid, high-quality DNA synthesis,... Read more